Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

Health

Eye Tests Show Promise in Predicting Parkinson’s Disease Progression

A recent study has shown promising results in using eye tests to predict the progression of Parkinson’s disease. Researchers have found that measuring the thickness of the retina through optical coherence tomography can help monitor neurodegeneration in Parkinson’s patients.

The study, conducted from 2015 to 2021, revealed a significant thinning of the retinal layer in Parkinson’s patients, which was correlated with the severity of the disease. This suggests that changes in the retina could serve as an early indicator of cognitive and motor decline in Parkinson’s disease.

By identifying retinal degeneration before the onset of other symptoms, routine eye exams could potentially become a non-invasive tool for predicting the future severity of Parkinson’s symptoms. This could lead to more targeted treatment strategies and better clinical outcomes for patients.

Dr. Ane Murueta-Goyena, a researcher involved in the study, highlighted the importance of being able to predict disease progression in Parkinson’s patients. The variability in the evolution of the disease makes it challenging for neurologists to provide accurate prognoses, but monitoring retinal thickness could offer valuable insights into the potential cognitive decline and disease progression.

While there are still some aspects that need further confirmation for clinical use and improvements in resolution, the study’s findings suggest that routine eye exams could play a significant role in monitoring neurodegeneration in Parkinson’s patients. This innovative approach could revolutionize the way Parkinson’s disease is managed and provide patients with more personalized and effective treatment options.

LEAVE A RESPONSE

Your email address will not be published. Required fields are marked *